|4Jun 29, 10:19 AM ET

Knaley Brian 4

4 · Surna Inc. · Filed Jun 29, 2021

Insider Transaction Report

Form 4
Period: 2021-06-28
Knaley Brian
DirectorCFO/Treasurer
Transactions
  • Award

    Option to purchase common stock

    2021-06-28+250,000250,000 total
    Exercise: $0.06From: 2021-06-28Exp: 2031-06-30Common Stock (250,000 underlying)
  • Award

    Option to purchase common stock

    2021-06-28+665,000665,000 total
    Exercise: $0.06From: 2023-06-30Exp: 2031-06-30Common Stock (665,000 underlying)
  • Award

    Option to purchase common stock

    2021-06-28+668,000668,000 total
    Exercise: $0.06From: 2024-06-30Exp: 2031-06-30Common Stock (668,000 underlying)
  • Award

    Option to purchase common stock

    2021-06-28+417,000417,000 total
    Exercise: $0.06From: 2022-06-30Exp: 2031-06-30Common Stock (417,000 underlying)
Footnotes (4)
  • [F1]Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which were vested and exercisable on the date of grant. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
  • [F2]Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which vest and become exercisable on June 30, 2022. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
  • [F3]Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which vest and become exercisable on June 30, 2023. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
  • [F4]Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which vest and become exercisable on June 30, 2024. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.

Documents

1 file
  • 4
    ownership.xmlPrimary